PTHS Latest Press Releases

-- October 6, 2026 --

Pelthos Therapeutics Announces Expanded Formulary Coverage for ZELSUVMI (berdazimer) Topical Gel, 10.3% Globe Newswire 8:00 AM

-- August 13, 2026 --

Pelthos Therapeutics Announces Second Quarter 2026 Financial Results Globe Newswire 7:10 AM

-- August 3, 2026 --

Pelthos Therapeutics to Report Second Quarter 2026 Financial Results on August 13, 2026 Globe Newswire 8:00 AM

-- July 24, 2026 --

Pelthos Therapeutics Announces 2026 Annual Meeting of Stockholders Globe Newswire 5:00 PM

-- June 30, 2026 --

Pelthos Therapeutics Added to Russell 3000E Growth Benchmark, Russell Microcap and Russell Microcap Growth Benchmark Indexes Globe Newswire 4:15 PM

Palvella Therapeutics Appoints Accomplished Rare Disease Biotech Executive and Commercial Leader Matt Pauls, J.D., M.B.A., to Board of Directors Globe Newswire 7:30 AM

-- May 28, 2026 --

Pelthos Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference Globe Newswire 5:00 PM

Market Data Delayed 15 Minutes